Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling

K-Number: K201723 · 2021-03-16

Decision Date2021-03-16
Product CodeBTT
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling is a medical device manufactured by Fisher & Paykel Healthcare, Ltd.. It received FDA 510(k) clearance on 2021-03-16 under approval number K201723. The device is classified under product code BTT. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling?

F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling is a medical device that received FDA 510(k) clearance on 2021-03-16. It is manufactured by Fisher & Paykel Healthcare, Ltd.. The 510(k) number is K201723.

When was F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling approved by the FDA?

F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling received FDA 510(k) clearance on 2021-03-16, under approval number K201723.

What company makes F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling?

F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling is manufactured by Fisher & Paykel Healthcare, Ltd..

What is the FDA product code for F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling?

The FDA product code for F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling is BTT.

Related Clinical Trials

Other Devices by Fisher & Paykel Healthcare, Ltd.

View all 25 devices →

Related Devices (Code: BTT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.